The U.S. Food and Drug Administration (FDA) has authorized a device called the Valeda Light Delivery System for treating dry age-related macular degeneration (AMD). The device uses a technology called photobiomodulation, which harnesses light at three specific wavelengths to improve retinal health, reduce inflammation, and enhance visual clarity.

In clinical trials, participants who received Valeda treatment saw significant vision improvement and preservation lasting as long as 24 months, particularly for those in the early or intermediate stages of AMD. Researchers also saw a reduction in the number of people who progressed to severe geographic atrophy, a late-stage AMD condition where retinal cells break down, causing central vision loss. In clinical trials, no significant side effects were reported.

Treatment with the Valeda Light System is administered by eye care professionals. The procedure is straightforward: A person is seated at the device and receives light treatments lasting about four minutes per session. A typical course of treatment involves nine sessions — three sessions per week for three to four weeks.

A Potential Game-Changer for Dry AMD

Dry AMD is a leading cause of vision loss among U.S. adults over 60, often impacting daily activities like driving and reading. Until now, there have been no FDA-approved treatments for dry AMD. While lifestyle changes, dietary supplements, and routine monitoring can slow disease progression, Valeda is the first therapy that may actively improve visual acuity and address underlying damage to retinal cells. Importantly, the trials demonstrated benefits for individuals with intermediate AMD. Those with more advanced stages of AMD, such as central geographic atrophy or wet AMD, may not experience the same benefits.

If you or a loved one is living with dry AMD, consider speaking to your ophthalmologist about available options to help preserve your vision.

Read about five other treatments for dry AMD, including supplements, injections, and lifestyle changes.

Find Your Team

On myAMDteam, the social network for people living with macular degeneration and their loved ones, members come together to ask questions, give advice, and share their stories with others who understand life with AMD.

What challenges have you faced with AMD treatment? How have therapies impacted your daily life? Share your experiences in a comment below, or start a conversation on your Activities page.